Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostate Cancer Metastatic × Dexamethasone × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 58 Burkitt Lymphoma 9 Recurrence 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Immunoglobulin Light-chain Amyloidosis 7 Neoplasms 6 Prostatic Neoplasms 5 Leukemia, Biphenotypic, Acute 4 Paraproteinemias 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 beta-Thalassemia 1 Vomiting 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Supratentorial Neoplasms 1 Smoldering Multiple Myeloma 1 Renal Insufficiency 1 Rectal Neoplasms 1 Radiation Pneumonitis 1

Interventions

fludrocortisone acetate 1 enzalutamide 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiosurgery 1 Prednisone 1 Hydrocortisone 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06136624 2026-03-11

OMAHA-003

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡